查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585802

腦腫瘤診斷和治療市場：按治療、診斷和類型分類 - 全球預測 2025-2030

Brain Tumor Diagnosis & Treatment Market by Treatment (Chemotherapy, Immunotherapy, Radiation Therapy), Diagnosis (CT Scan, EEG, Molecular Testing), Type - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

腦瘤診斷與治療市場2023年估值為16.9億美元，預計到2024年將達到18億美元，複合年成長率為6.85%，到2030年預計將達到26.9億美元。

腦腫瘤診斷和治療市場範圍廣泛，涵蓋檢測和管理腦腫瘤的技術和方法，例如影像技術、手術、放射線治療和新藥開拓。這種需求源於解決神經系統疾病的迫切需要，其中人口老化和環境因素導致的盛行率增加增加了對更有效和侵入性較小的診斷和治療技術的需求。最終用途主要針對神經學和腫瘤學專業的醫療保健專業人員。關鍵的成長要素包括 MRI 和電腦斷層掃描等醫療圖像技術的進步，以及提高治療效果和患者預後的標靶治療和個人化醫療方法的創新。此外，人工智慧和成像技術的結合提高了早期診斷的準確性，以及基因療法和免疫療法等生物技術解決方案的開拓，有望帶來顯著的市場成長。為了利用這些機會，鼓勵公司投資研發，促進與研究機構的合作，並與監管機構合作，以加速新治療方法的上市時間。

主要市場統計
基準年[2023] 16.9億美元
預測年份 [2024] 18億美元
預測年份 [2030] 26.9億美元
複合年成長率（%） 6.85%

該市場主要受到高昂的治療成本、嚴格的法律規範以及腦病理生理學的複雜性的限制，阻礙了新治療方法的快速開發。此外，在對從業人員進行新技術教育和獲得患者信任方面也存在挑戰。創新研究領域包括探索非侵入性診斷、尖端基因分析、液態切片技術和血腦障壁滲透性技術以改善藥物傳輸。了解競爭格局至關重要。這是因為市場非常活躍，新興企業和老牌公司不斷發展其產品線。我們對精準醫療和即時資料分析的關注為不斷變化的患者需求和治療方案提供了重要的見解。

市場動態：快速發展的腦腫瘤診斷和治療市場的關鍵市場洞察

供需的動態交互作用正在改變腦腫瘤診斷和治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 腦腫瘤和其他神經系統疾病的增加
    • 需要早期診斷以提高患者存活率並開發新的個人化治療
    • 腦細胞診斷設備技術不斷進步
  • 市場限制因素
    • 特異性藥物的供應和學名藥的使用增加
    • 與治療生物侵襲性腫瘤相關的獨特問題
  • 市場機會
    • 安寧療護和臨床試驗激增腦腫瘤治療
    • 發明新藥和治療治療方法
  • 市場挑戰
    • 新興國家診斷和治療費用上升

波特五力：駕馭腦瘤診斷與治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對腦腫瘤診斷和治療市場的影響

外部宏觀環境因素對腦腫瘤診斷和治療市場的績效動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解腦腫瘤診斷與治療市場的競爭格局

對腦腫瘤診斷和治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣腦腫瘤診斷與治療市場供應商的績效評估

FPNV定位矩陣是評估腦腫瘤診斷和治療市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了腦腫瘤診斷和治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對腦腫瘤診斷和治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腦腫瘤和其他神經系統疾病的發生率增加
      • 早期診斷對於提高患者存活率和開發新的個人化治療是必要的
      • 加速腦細胞診斷設備技術進步
    • 抑制因素
      • 增加特異性藥物的供應和學名藥的使用
      • 與生物侵襲性腫瘤的治療相關的獨特問題
    • 機會
      • 透過安寧療護和臨床試驗加速腦腫瘤治療
      • 發明新藥和治療治療方法
    • 任務
      • 新興國家診療費用高
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 按治療分類的腦腫瘤診斷與治療市場

  • 化療
  • 免疫療法
  • 放射治療
  • 放射線手術
  • 外科手術
  • 標靶藥物治療

第7章 依診斷分類的腦腫瘤診療市場

  • 電腦斷層掃描
  • 腦電波
  • 分子檢測
  • MRI
  • PET- 電腦斷層掃描

第8章腦腫瘤診斷與治療市場：按類型

  • 原發性腦腫瘤
  • 次發性腦腫瘤

第9章美洲腦腫瘤診療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太腦腫瘤診療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲腦腫瘤診療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amgen Inc.
  • AstraZeneca PLC
  • Canon Medical Systems Corporation
  • Carestream Health, Inc.
  • Eisai Co., Ltd.
  • Elekta AB
  • GE Healthcare
  • Hitachi Medical Systems
  • Koninklijke Philips NV
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Shimadzu Corporation
  • Siemens Healthineers AG
  • Varian Medical Systems, Inc.
Product Code: MRR-437D459585B5

The Brain Tumor Diagnosis & Treatment Market was valued at USD 1.69 billion in 2023, expected to reach USD 1.80 billion in 2024, and is projected to grow at a CAGR of 6.85%, to USD 2.69 billion by 2030.

The scope of the Brain Tumor Diagnosis & Treatment market is expansive, encompassing technologies and methods for detecting and managing brain tumors, including imaging techniques, surgical procedures, radiation therapies, and novel drug developments. Its necessity stems from the urgent need to address neurological diseases, with increasing prevalence due to aging populations and environmental factors driving demand for more effective and less invasive diagnostic and therapeutic technologies. In terms of application, this market spans from hospitals and diagnostic centers to research institutions, with end-use primarily focusing on medical professionals specializing in neurology and oncology. Key growth factors include advancements in medical imaging technologies, such as MRI and CT scans, along with innovation in targeted therapies and personalized medicine approaches that enhance treatment efficacy and patient outcomes. Latest potential opportunities can be found in combining artificial intelligence with imaging technologies to improve accuracy in early diagnosis, and the development of biotechnological solutions like gene therapies and immunotherapies which promise significant market growth. To capitalize on these opportunities, companies are recommended to invest in research and development, foster collaborations with research institutes, and engage with regulatory bodies to expedite the time-to-market for new treatments.

KEY MARKET STATISTICS
Base Year [2023] USD 1.69 billion
Estimated Year [2024] USD 1.80 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 6.85%

The market does face limitations, primarily due to the high cost of treatment, stringent regulatory frameworks, and the complex nature of brain pathophysiology that hinders rapid development of new therapies. Moreover, there exists a challenge in educating practitioners about new technologies and gaining patient trust. Innovative areas for research include exploring non-invasive diagnostic methods, cutting-edge genetic profiling, liquid biopsy technologies, and techniques for enhancing blood-brain barrier permeability to improve drug delivery. Understanding the competitive landscape is crucial, as the market is highly dynamic with emerging players and established companies continually evolving their product lines. Focus on precision medicine and real-time data analytics can offer significant insights into evolving patient needs and treatment protocols, crucial for thriving in this challenging yet promising market arena.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Brain Tumor Diagnosis & Treatment Market

The Brain Tumor Diagnosis & Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of brain cancer and other neurological disorders
    • Need for early diagnostic to improve the survival rate of patients and to develop new personalized treatments
    • Increasing technological advancement in brain cells diagnostics devices
  • Market Restraints
    • Availability of nonspecific drugs and growing use of generics treatments
    • Unique concern associated with the treatment of biologically aggressive tumors
  • Market Opportunities
    • Palliative care and clinical trials to surge the brain tumor treatment
    • Inventions of novel drugs and therapies for the treatment
  • Market Challenges
    • Heavy cost of diagnosis and treatment in emerging economies

Porter's Five Forces: A Strategic Tool for Navigating the Brain Tumor Diagnosis & Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Brain Tumor Diagnosis & Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Brain Tumor Diagnosis & Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Brain Tumor Diagnosis & Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Brain Tumor Diagnosis & Treatment Market

A detailed market share analysis in the Brain Tumor Diagnosis & Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Brain Tumor Diagnosis & Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Brain Tumor Diagnosis & Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Brain Tumor Diagnosis & Treatment Market

A strategic analysis of the Brain Tumor Diagnosis & Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Tumor Diagnosis & Treatment Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., AstraZeneca PLC, Canon Medical Systems Corporation, Carestream Health, Inc., Eisai Co., Ltd., Elekta AB, GE Healthcare, Hitachi Medical Systems, Koninklijke Philips N.V., Merck & Co., Inc., Pfizer Inc., Shimadzu Corporation, Siemens Healthineers AG, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Tumor Diagnosis & Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Chemotherapy, Immunotherapy, Radiation Therapy, Radiosurgery, Surgery, and Targeted Drug Therapy.
  • Based on Diagnosis, market is studied across CT Scan, EEG, Molecular Testing, MRI, and PET-CT Scan.
  • Based on Type, market is studied across Primary Brain Tumor and Secondary Brain Tumor.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of brain cancer and other neurological disorders
      • 5.1.1.2. Need for early diagnostic to improve the survival rate of patients and to develop new personalized treatments
      • 5.1.1.3. Increasing technological advancement in brain cells diagnostics devices
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of nonspecific drugs and growing use of generics treatments
      • 5.1.2.2. Unique concern associated with the treatment of biologically aggressive tumors
    • 5.1.3. Opportunities
      • 5.1.3.1. Palliative care and clinical trials to surge the brain tumor treatment
      • 5.1.3.2. Inventions of novel drugs and therapies for the treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Heavy cost of diagnosis and treatment in emerging economies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Brain Tumor Diagnosis & Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Chemotherapy
  • 6.3. Immunotherapy
  • 6.4. Radiation Therapy
  • 6.5. Radiosurgery
  • 6.6. Surgery
  • 6.7. Targeted Drug Therapy

7. Brain Tumor Diagnosis & Treatment Market, by Diagnosis

  • 7.1. Introduction
  • 7.2. CT Scan
  • 7.3. EEG
  • 7.4. Molecular Testing
  • 7.5. MRI
  • 7.6. PET-CT Scan

8. Brain Tumor Diagnosis & Treatment Market, by Type

  • 8.1. Introduction
  • 8.2. Primary Brain Tumor
  • 8.3. Secondary Brain Tumor

9. Americas Brain Tumor Diagnosis & Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain Tumor Diagnosis & Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain Tumor Diagnosis & Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amgen Inc.
  • 2. AstraZeneca PLC
  • 3. Canon Medical Systems Corporation
  • 4. Carestream Health, Inc.
  • 5. Eisai Co., Ltd.
  • 6. Elekta AB
  • 7. GE Healthcare
  • 8. Hitachi Medical Systems
  • 9. Koninklijke Philips N.V.
  • 10. Merck & Co., Inc.
  • 11. Pfizer Inc.
  • 12. Shimadzu Corporation
  • 13. Siemens Healthineers AG
  • 14. Varian Medical Systems, Inc.

LIST OF FIGURES

  • FIGURE 1. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY RADIOSURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TARGETED DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY CT SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY EEG, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MOLECULAR TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY MRI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PET-CT SCAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY PRIMARY BRAIN TUMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY SECONDARY BRAIN TUMOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 52. CHINA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 55. INDIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 58. INDONESIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 61. JAPAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 64. MALAYSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 67. PHILIPPINES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 70. SINGAPORE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 73. SOUTH KOREA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 76. TAIWAN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 79. THAILAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 82. VIETNAM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 89. DENMARK BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 92. EGYPT BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 95. FINLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 98. FRANCE BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 101. GERMANY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 104. ISRAEL BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 107. ITALY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 110. NETHERLANDS BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 113. NIGERIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 116. NORWAY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 119. POLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 122. QATAR BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 125. RUSSIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 128. SAUDI ARABIA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH AFRICA BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 134. SPAIN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 137. SWEDEN BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 140. SWITZERLAND BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 143. TURKEY BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED ARAB EMIRATES BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
  • TABLE 149. UNITED KINGDOM BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 151. BRAIN TUMOR DIAGNOSIS & TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023